Patent · US Active

2-pyridone derivatives as neutrophil elastase inhibitors and their use

US8063073B2 · kind B2 · utility

2Cited by

7References

4Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Peter Hansen · Staffanstorp, SE
Hans Roland LONN · Lund, SE
Antonios Nikitidis · Lund, SE

Key dates

Filing date	Sep 15, 2004
Grant date	Nov 22, 2011
Priority date	—
Expiry date	Jul 26, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are provided novel compounds of formula (I), wherein R1, R2, R4, R5, G1, G2, L, Y and n are as defined in the Specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of neutrophil elastase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.